Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1722876
PUBLISHER: IMARC | PRODUCT CODE: 1722876
Anti-Obesity Drugs Market Size, Share, Trends and Forecast by Drug Class, Drug Type, Distribution Channel, and Region, 2025-2033
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global anti-obesity drugs market size was valued at USD 2.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.9 Billion by 2033, exhibiting a CAGR of 9.89% from 2025-2033. North America currently dominates the market, holding a market share of over 36.7% in 2024. The anti-obesity drugs market share is increasing due to the rising obesity rates, health awareness, demand for weight management solutions, drug development advancements, government initiatives, R&D investments, combination therapies, and availability of prescription and over-the-counter drugs.
Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They help reduce cravings and control compulsive eating, especially for sweets and fatty, salty, and high-calorie food products. They can also provide independent health benefits, such as controlling blood pressure, harmful lipid levels, waist circumference, sugar levels and nonalcoholic fatty liver disease (NAFLD) and minimize the risk of major cardiovascular diseases (CVDs) and progression of diabetic kidney disease.
Anti-Obesity Drugs Market Trends:
Recent advances in anti-obesity drugs have enabled the potential of attaining clinically significant weight loss among individuals. This, in confluence with the widespread prevalence of obesity on account of sedentary lifestyles, represents one of the key factors creating a positive outlook for the market. In addition, obesity increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases (CVD), and cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. It can also result in numerous psychological, neurological, pulmonary, gastrointestinal, renal, musculoskeletal, and endocrine diseases. Besides this, sleep deprivation, circadian desynchronization, chronic stress, and the rising use of anti-epileptic and psychotropic drugs may further induce weight gain. This, coupled with the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings, is fueling the growth of the market. Apart from this, weight loss aids in improving the quality of life, mobility, daily function, and psychological well-being of individuals. This, along with the increasing health consciousness, thriving pharmaceutical industry, and the rising focus on the management of diseases closely integrated with excess body weight, is anticipated to stimulate the growth of the market.
Key Market Segmentation:
Breakup by Drug Class:
- Peripherally Acting Drugs
- Centrally Acting Drugs
Breakup by Drug Type:
- Prescription Drugs
- OTC Drugs
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, Gelesis, GlaxoSmithKline plc, Merck & Co. Inc., Norgine B.V., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals Inc., SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Vivus LLC.
Key Questions Answered in This Report
- 1.How big is the anti-obesity drugs market?
- 2.What is the future outlook of anti-obesity drugs market?
- 3.What are the key factors driving the anti-obesity drugs market?
- 4.Which region accounts for the largest anti-obesity drugs market share?
- 5.Which are the leading companies in the global anti-obesity drugs market?
Product Code: SR112025A5544
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anti-Obesity Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 Peripherally Acting Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Centrally Acting Drugs
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Prescription Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 OTC Drugs
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Pharmacy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Boehringer Ingelheim International GmbH
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Currax Pharmaceuticals LLC
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Gelesis
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 GlaxoSmithKline plc
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Merck & Co. Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Norgine B.V.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Novo Nordisk A/S
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Rhythm Pharmaceuticals Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.10 SHIONOGI & Co. Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Vivus LLC
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Boehringer Ingelheim International GmbH
Product Code: SR112025A5544
List of Figures
- Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2024
- Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2024
- Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2024
- Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Anti-Obesity Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Anti-Obesity Drugs (OTC Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Anti-Obesity Drugs (OTC Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Anti-Obesity Drugs (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Anti-Obesity Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Anti-Obesity Drugs (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Anti-Obesity Drugs (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: North America: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: North America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: United States: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: United States: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Canada: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Canada: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Asia-Pacific: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Asia-Pacific: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: China: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: China: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Japan: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Japan: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: India: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: India: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: South Korea: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: South Korea: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Australia: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Australia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Indonesia: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Indonesia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Others: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Europe: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Europe: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Germany: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Germany: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: France: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: France: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: United Kingdom: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: United Kingdom: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Italy: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Italy: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Spain: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Spain: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Russia: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Russia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Others: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Latin America: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Latin America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Brazil: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Brazil: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Mexico: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Mexico: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Others: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Middle East and Africa: Anti-Obesity Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Middle East and Africa: Anti-Obesity Drugs Market: Breakup by Country (in %), 2024
- Figure 70: Middle East and Africa: Anti-Obesity Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Global: Anti-Obesity Drugs Industry: SWOT Analysis
- Figure 72: Global: Anti-Obesity Drugs Industry: Value Chain Analysis
- Figure 73: Global: Anti-Obesity Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Anti-Obesity Drugs Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
- Table 3: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 4: Global: Anti-Obesity Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 5: Global: Anti-Obesity Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Anti-Obesity Drugs Market: Competitive Structure
- Table 7: Global: Anti-Obesity Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.